TANZI, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 16.092
NA - Nord America 8.941
AS - Asia 5.016
SA - Sud America 387
AF - Africa 137
OC - Oceania 75
Continente sconosciuto - Info sul continente non disponibili 8
Totale 30.656
Nazione #
US - Stati Uniti d'America 8.537
GB - Regno Unito 7.125
IT - Italia 3.341
CN - Cina 1.756
DE - Germania 1.501
SE - Svezia 1.299
SG - Singapore 1.206
RU - Federazione Russa 654
TR - Turchia 560
IN - India 435
KR - Corea 401
FR - Francia 393
CA - Canada 373
UA - Ucraina 367
IE - Irlanda 361
BR - Brasile 249
NL - Olanda 242
FI - Finlandia 235
EU - Europa 185
ID - Indonesia 183
VN - Vietnam 141
DK - Danimarca 132
CO - Colombia 80
HK - Hong Kong 80
BE - Belgio 73
AU - Australia 64
PL - Polonia 55
ES - Italia 51
NO - Norvegia 49
JP - Giappone 38
AT - Austria 32
RO - Romania 30
CH - Svizzera 29
PH - Filippine 25
IR - Iran 23
GR - Grecia 22
MX - Messico 22
TW - Taiwan 20
TZ - Tanzania 19
TH - Thailandia 17
IQ - Iraq 15
AR - Argentina 14
SA - Arabia Saudita 14
KE - Kenya 13
PE - Perù 13
UZ - Uzbekistan 13
ZA - Sudafrica 13
BD - Bangladesh 12
CZ - Repubblica Ceca 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
MA - Marocco 11
NZ - Nuova Zelanda 11
PK - Pakistan 11
PT - Portogallo 11
BY - Bielorussia 10
EG - Egitto 10
ET - Etiopia 10
LT - Lituania 10
MY - Malesia 10
RS - Serbia 9
EC - Ecuador 8
SK - Slovacchia (Repubblica Slovacca) 8
IL - Israele 7
KZ - Kazakistan 7
AL - Albania 6
LB - Libano 6
VE - Venezuela 6
BG - Bulgaria 5
BO - Bolivia 5
HU - Ungheria 5
LU - Lussemburgo 5
NG - Nigeria 5
TN - Tunisia 5
UG - Uganda 5
BW - Botswana 4
CL - Cile 4
GA - Gabon 4
JO - Giordania 4
LV - Lettonia 4
MT - Malta 4
PA - Panama 4
SC - Seychelles 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
CI - Costa d'Avorio 3
NP - Nepal 3
OM - Oman 3
RW - Ruanda 3
ZM - Zambia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
CR - Costa Rica 2
CU - Cuba 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
Totale 30.807
Città #
Southend 6.794
Chandler 977
Milan 901
Singapore 738
Seattle 649
Princeton 451
Fairfield 443
Houston 430
Wilmington 420
Ashburn 402
Beijing 375
Dublin 352
Ann Arbor 328
Council Bluffs 308
Toronto 258
Frankfurt am Main 251
Woodbridge 228
Jacksonville 227
Redmond 227
Santa Clara 220
Hanover 206
Rome 195
Nanjing 189
Mountain View 182
Boardman 171
Des Moines 163
Sakarya 155
Dearborn 148
Cambridge 137
Bengaluru 122
Jakarta 122
Redwood City 101
Andover 95
Serra 94
Berlin 85
Somerville 82
Ottawa 81
Shenyang 81
Bogotá 74
New York 74
Grafing 69
Nanchang 69
Shanghai 68
Jinan 66
Phoenix 62
Dong Ket 61
Guangzhou 59
Brussels 58
Istanbul 57
Seoul 51
London 50
Los Angeles 49
Changsha 48
Hong Kong 47
Hebei 46
Nuremberg 42
Florence 41
Eitensheim 40
Saint Petersburg 40
Turin 40
Helsinki 39
Warsaw 38
Hangzhou 36
São Paulo 34
Fremont 33
Pisa 33
Tianjin 33
Falls Church 32
Fuzhou 32
Norwalk 32
San Diego 31
Bitonto 30
Medford 30
Hemet 29
Jiaxing 28
Kiez 28
Zhengzhou 28
Naples 27
Bühl 26
Nürnberg 26
Silver Spring 24
Washington 23
Bergamo 21
Hefei 21
Napoli 21
Piscataway 20
Amsterdam 19
Kunming 19
Munich 19
Auburn Hills 18
Vienna 18
Wuhan 18
Chicago 17
Dar es Salaam 17
Kent 17
Lanzhou 17
Ningbo 17
Sunnyvale 17
Verona 17
Bologna 16
Totale 19.600
Nome #
Vaccinazione antinfluenzale in soggetti con cirrosi epatica cronica e trapiantati di fegato 1.173
Sexually Transmitted Infections : A Novel Screening Strategy for Improving Women’s Health in Vulnerable Populations 694
Ongoing large measles outbreak with nosocomial transmission in Milan, northern Italy, March-August 2017 687
Distribution of Marburg virus in Africa: An evolutionary approach 678
Significato clinico della variabilità virale : il virus dell'epatite B 633
Measles surveillance activities in the Metropolitan Area of Milan during 2017-2018 424
High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping 352
Prevalence of human papillomavirus in young Italian women with normal cytology : how should we adapt the national vaccination policy? 313
Detection and Genotyping of Human Papillomavirus in Urine Samples from Unvaccinated Male and Female Adolescents in Italy 307
Modifiable and non-modifiable factors related to HPV infection and cervical abnormalities in women at high risk: a cross-sectional analysis from the Valhidate Study 278
Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women 257
Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS 249
Spatial and temporal dynamics of hepatitis B virus d genotype in europe and the mediterranean basin 239
Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV Infections and relATEd cervical diseases in high-risk women (VALHIDATE study) 235
Hepatitis B virus genotypes distribution in individuals with chronic HBV infection and in patients with HBV/HIV-1 co-infection living in Italy 230
Differential diagnosis of fever and rash cases negative for measles and rubella to complement surveillance activities 224
Genetic characterisation of Measles virus variants identified during a large epidemic in Milan, Italy, March–December 2017 224
Anti-LAV/HTLV-III antibodies in high and low risk groups 223
Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019 221
Outbreak of a new measles B3 variant in the Roma/Sinti population, with transmission in the nosocomial setting, Italy, November 2015-April 2016 218
HPV testing from dried urine spots as a tool for cervical cancer screening in low-income countries 217
Influenza and other respiratory viruses involved in severe acute respiratory disease in northern Italy during the pandemic and post pandemic period (2009-2011) 217
Dried Blood Spot as an Alternative to Plasma/ Serum for SARS-CoV-2 IgG Detection, an Opportunity to Be Sized to Facilitate COVID-19 Surveillance Among Schoolchildren 202
Human papillomavirus detection in paraffin-embedded colorectal cancer tissues 201
Valutazione dell’immunogenicità e della persistenza dell’immunità indotta da una dose di vaccinoantinfluenzale adiuvato virosomale in bambini infetti da HIV 200
Reliable timescale inference of HBV genotype A origin and phylodynamics 198
Long-lasting immunogenicity of a virosomal influenza vaccine in older children and young adults with type I diabetes mellitus 197
Immunogenicità a lungo termine di una dose di vaccino antinfluenzale adiuvato virosomale in bambini affetti da asma bronchiale 193
Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy 193
Low seroprevalence of SARS-CoV-2 infection among healthcare workers of the largest children hospital in Milan during the pandemic wave 192
Viable newcastle disease vaccine strains in a pharmaceutical dump 191
Genetic characterization of variants of HPV‑16, HPV‑18 and HPV‑52 circulating in Italy among general and high‑risk populations 188
HPV genotypes detected in the oropharyngeal mucosa of HIV-infected men who have sex with men in Northern Italy 187
Anal HPV genotypes and related displasic lesions in Italian and foreign born high-risk males 179
Viability of vaccine strains in a pharmaceutical dump 173
Genetic variability of the measles virus hemagglutinin gene in B3 genotype strains circulating in Northern Italy 173
Impact of combined sewer overflows on water quality of rural canals in agro-urban environments 172
Chlamydia trachomatis prevalence and chlamydial/ HPV co-infection among HPV-unvaccinated young italian females with normal cytology 170
Hepatitis B vaccination of 113 hemophiliacs: lower antibody response in anti-LAV/HTLV-III-positive patients 169
Human Papillomavirus (HPV) infection and genotype frequency in the oral mucosa of newborns in Milan, Italy 169
Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE study 167
Circulating influenza virus types and subtypes in Lombardy (Italy) during the 2006/2007 season 165
Time-scaled phylogeography of complete Zika virus genomes using discrete and continuous space diffusion models 165
Molecular characterization and phylogenetic analysis of human influenza A viruses in three consecutive seasons with different epidemiological profiles 164
Molecular evidence of Listeria monocytogenes infection relapse in a severe case of endocarditis 164
High-resolution diffusion pattern of human infections by Salmonella enterica serovar Napoli in Northern Italy explained through phylogeography 163
Viability of live-attenuated vaccine strains in a pharmaceutical dump 162
Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low‐ and middle‐income countries 160
Virological-molecular study of aetiological agents associated to Influenza-Like Illness (ILI) 158
Influenza aviaria e influenza umana: esiste un rischio pandemico? 158
Rapid molecular evolution of human bocavirus revealed by Bayesian coalescent inference 156
Co-circulation of genetically distinct human Metapneumovirus anf human Bocavirus strains in young children with respiratory tract infections in Italy 156
Biological risk stemming from the long-term burial of NDV vaccinal strains 155
Human Metapneumovirus and human Bocavirus in hospitalised children with acute respiratory infections 154
Vitalità di ceppi vaccinali di NDV rinvenuti dopo oltre 20 anni di interramento 153
Epidemiology of Respiratory Syncytial Virus (RSV) and human Metapneumovirus (hMPV) infections among hospitalized children in Italy 151
Vaccinazione anti-influenzale in una coorte di soggetti emodializzati: cross-reattività degli anticorpi vaccino-indotti con il ceppo virale epidemico nella stagione 2003/04 151
Molecular characterization of influenza viruses circulating in Northern Italy during two seasons (2005/2006 and 2006/2007) of low influenza activity 151
Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy 150
Biological risk stemming from the long-term burial of vaccinal strains 150
Molecular epidemiology of B3 and D8 measles viruses through hemagglutinin phylogenetic history 150
Use of Dried Blood Spots (DBS) for performing epidemiological analysis in developing Countries 149
Time and mode of epidemic hcv-2 subtypes spreading in Europe: Phylodynamics in Italy and Albania 149
Impact of Respiratory Syncityal Virus and human Metapneumovirus infections among hospitalized children younger than 3 years of age 148
High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus 147
Persistenza anticorpale indotta da una dose di vaccino anti-influenzale adiuvato virosomale in bambini affetti da asma bronchiale 147
Laboratory-based surveillance of invasive listeriosis in Northern Italy over a fourteen-year period: Epidemiological and clinical results 147
Dating the origin and dispersal of human papillomavirus type 16 on the basis of ancestral human migrations 146
Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania 145
Viability evaluation of long-term burial of Newcastle Disease Virus (NDV) vaccine strains 143
Molecular characterization and phylogenetic analysis of human influenza A viruses in 3 consecutive seasons with different epidemiological profiles 141
Hepatitis B virus genotype distribution in HIV-1 coinfected patients. 141
A prospective study on mother-to-infant transmission of hepatitis C virus 140
HPV Type-Specific Prevalence a Decade after the Implementation of the Vaccination Program: Results from a Pilot Study 140
Ottimizzazione di saggi di sopravvivenza di virus enterici nel suolo 139
Applicazione della metodica Ethidium Monoazide (EMA) Real Time PCR su ceppi di Legionella pneumophila vivi e VBNC (Viable But Not Cultivable) 139
Different evolutionary rates and epidemic growth of hepatitis B virus genotypes A and D 138
Strategie di contenimento del rischio biologico adottate nella bonifica della discarica dell’Istituto Sieroterapico Milanese: un intervento di Sanità Pubblica 138
Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18-25 years) in Milan, Italy 137
Sorveglianza epidemiologico-molecolare degli agenti virali responsabili di infezioni respiratorie acute in una coorte di soggetti ad elevata incidenza di ARI 136
Determinazione di cellule B di memoria HBsAg-specifiche in una coorte di soggetti vaccinati contro l’epatite B da oltre 10 anni 135
Studio virologico-molecolare degli agenti eziologici associati ad Influenza-Like Illness (ILI) (Influnet, Regione Lombardia, Stagione 2006/07) 134
Pandemic influenza vaccine in adult HIV-1-infected patients 134
Epidemiological and clinical features of respiratory viral infections in hospitalized children during the circulation of influenza virus A(H1N1) 2009 134
Human Papillomavirus typing in a cohort of HIV-1-infected men in Milan, Italy 133
Rischio biologico da bio-materiali interrati in aree dismesse : un emergente problema di sanità pubblica 133
HCV e test per la sua identificazione. 133
Reappraisal of the Berg method to assess viral contamination of the soil 132
Epidemiologia molecolare dell’infezione da HPV in soggetti ad elevato rischio in Italia 132
Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi’s sarcoma 131
Screening of pregnant women and hepatitis B prophylaxis in newborns 131
Hepatitis C in pregnancy and mother-to-infant transmission of HCV 130
Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs 130
Genetic variability in the major capsid L1 protein of human papillomavirus type 16 (HPV-16) and 18 (HPV-18) 130
Sorveglianza dell'influenza in età pediatrica (2004-2005) 128
Vaccination against hepatitis B: the Italian strategy. 128
Yeast derived hepatitis B vaccine in dental students. A three-year follow-up study 128
Phylogeny and population dynamics of respiratory syncytial virus (Rsv) A and B 127
Confirmation of anti-HCV EIA reactivities by RIBA and neutralization assay among blood donors and patients with chronic liver disease and hepatocellular carcinoma. 126
Importanza della conferma dei campioni anti-HTLV-I positivi al test EIA 125
Totale 20.267
Categoria #
all - tutte 89.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020834 0 0 0 0 0 0 0 0 0 438 200 196
2020/20214.694 202 272 426 295 459 334 340 250 588 406 774 348
2021/20223.621 282 277 376 234 325 165 237 179 430 305 294 517
2022/20233.541 422 373 302 365 424 620 60 255 360 40 218 102
2023/20242.764 115 230 145 146 614 211 186 187 100 181 281 368
2024/20253.616 277 573 219 604 491 310 241 593 301 7 0 0
Totale 32.402